Key indicators: single-crystal X-ray study; T = 295 K; mean (C-C) = 0.007 Å; disorder in main residue; R factor = 0.036; wR factor = 0.073; data-to-parameter ratio = 18.1.
In the heterodinuclear complex of the title compound, [PbZn(C 22 H 18 N 2 O 4 )Cl 2 (C 2 H 6 OS)]ÁC 3 H 7 NO, the Zn II atom is coordinated in a distorted square-pyramidal geometry by two N atoms and two O atoms from the diphenolate ligand, and one Cl atom which occupies the apical position. The Pb II atom is coordinated in a distorted octahedral geometry by the four O atoms of the diphenolate ligand, one O atom from the dimethyl sulfoxide molecule and one Cl atom. The dimethyl sulfoxide molecule is disordered over two positions, with site occupancies of 0.576 (2) and 0.424 (2). 
Related literature

Experimental
Crystal data [PbZn(C 22 (Ward, 2007; Ni et al., 2005) . In addition, these compounds exist at the active sites of many metalloenzymes and play important roles in biological systems (Karlin, 1993) . Whereas, it is necessary to further widen the system of application of heterometallic compounds. Herein, a novel heterometallic binuclear Zn II Pb II compound has been obtained by step-by-step method and its structure is depicted.
As shown in Fig. 1 , the title compound is a binuclear neutral complex with a slightly distorted planar configuration. Each 
The H 2 L ligand and the complex ZnL were synthesized according to the previous literatures (Lo et al., 2004; Sui et al., 2007) . The title compound was obtained by allowing the mixture of ZnL (0.088 g, 0.2 mmol) and PbCl 2 .2H 2 O (0.063 g, 0.2 mmol) being refluxed in a DMF and DMSO (1:1) solution, cooled down to room temperature, then filtered. Yellow single crystals suitable for X-ray diffraction were obtained via slow evaporation of the filtrate at room temperature.
Refinement
All H atoms bound to C were refined using a riding model, with distance C-H = 0.93 Å and U iso (H) = 1.2U eq (C) for aromatic atoms, and C-H = 0.96 Å and U iso (H) = 1.5U eq (C) for methyl atoms. The DMSO molecule was found to be disordered over two positions in a difference Fourier map. All the atoms were refined in two parts and the site occupancy factors were refined to 0.576 (2) (for atoms S1, O5, C26 and C27) and 0.424 (2) (for atoms S1', O5', C26' and C27'). The bonds S-O and S-C were restrained to 1.45 (1) and 1.82 (1) Å, respectively. The displacement parameters of each pair of disorder atoms were set to equal by the EADP instruction. The bond lengths C26-S1, C26'-S1', C27-S1 and C27'-C1' were restrained to be nearly equal by the SADI command with deviation 0.01 Å. The distances of S1-O5 and Zn1-O5
were also restrained nearly equal to that of S1'-O5' and Zn1-O5', respectively. The displacement parameter restraints (DELU) were applied to the disorder atoms (S1, C27, S1' and C27'). Additionally, atoms C27 and C27' were restrained to be approximately isotropic by the ISOR instruction. Figures   Fig. 1 . A view of (I) with the unique atom-labelling scheme. Displacement ellipsoids are drawn at the 30% probability level, all hydrogen atoms are omitted for clarity. Only one conpoment of the disordered DMSO molecule is shown.
Crystal data [PbZn(C 22 Cell parameters from 5739 reflections a = 15.2850 (7) 1.418 (6) S1-O5 1.506 (5) C17-C18
1.349 (6) C27'-S1' 1.838 (7) C17-H17 0.9300 C27'-H27D 0.9600
